Completed

Standardized Contrast Study Protocol for Small Bowel Obstruction Management

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This observational study aims to examine the morbidity and length of stay associated with the standardized contrast study protocol for managing small bowel obstruction.

What is being collected

Data Collection

Collected from past medical records and data - Retrospective
Who is being recruted

From 18 to 89 Years
+4 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Other

Utilizing specific methods not covered by standard models in order to address unique research questions.
Observational
Study Start: July 2018
See protocol details

Summary

Principal SponsorMethodist Health System
Last updated: March 25, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: July 30, 2018

Actual date on which the first participant was enrolled.

This study is about reviewing different management strategies for Small Bowel Obstruction (SBO) across various institutions of the Southwestern Surgical Congress. The main goal is to understand if a standardized protocol involving a water soluble contrast study can improve the quality and safety of care, while also reducing the length of stay in the hospital and lowering the risk of complications for patients with SBO. The importance of this study lies in its potential to enhance patient care and recovery, addressing current challenges in managing SBO. In this observational study, researchers will look back at the records of patients admitted with SBO. They will focus on how a water soluble contrast study, a type of imaging test, was used as part of the treatment plan. The primary outcomes being measured are the morbidity (rate of complications) and the length of hospital stay. These outcomes will help determine if the use of the contrast study contributes to improved patient care and recovery.

Official TitleA Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction
NCT06223620
Principal SponsorMethodist Health System
Last updated: March 25, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

504 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other

Some studies use unique or mixed approaches that don't fit standard categories. These may include innovative observational methods or studies tailored to specific research questions.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 89 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

2 inclusion criteria required to participate
Patients presenting with SBO
Adults aged 18-89 years of age
2 exclusion criteria prevent from participating
Pregnant women
Prisoners

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Methodist Dallas Medical Center

Dallas, United StatesOpen Methodist Dallas Medical Center in Google Maps
CompletedOne Study Center